Coral Laboratories Fair Value
Coral Laboratories (CORALAB) average fair value is ₹37697.68 across 6 valuation models — P/E Based Valuation, P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Benjamin Graham Number, Discounted Cash Flow (DCF), vs a current market price of ₹456.75 (+8153.46%), fair value range ₹502.5–₹221914.13. For live price and a broader fundamental view, visit CORALAB stock price BSE.
Fair Value Analysis Export
CORALAB Fair Value vs Current Price — Valuation Summary
CORALAB average fair value, fair value range, price gap and valuation status across 6 models: P/E Based Valuation, P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Benjamin Graham Number, Discounted Cash Flow (DCF). See Coral Laboratories P/B valuation to compare market price against book value per share.
P/E Based Valuation
P/B Based Valuation
Price-to-Sales Valuation
Asset-Based Valuation
Benjamin Graham Number
Discounted Cash Flow (DCF)
CORALAB Fair Value Analysis — Data Sources & Coverage
Coral Laboratories financial data sources, valuation methods applied and sector benchmarks used. Also explore CORALAB stock price history to track price trends across different timeframes.
Available Data Sources: Financial statements, dividend history, balance sheet data , sector comparisons.
CORALAB vs Healthcare Sector Peers — P/E, P/B & Market Cap
Coral Laboratories P/E ratio, P/B ratio and market capitalisation vs Healthcare sector peers — relative valuation comparison.
| Company | Symbol | P/E Ratio | P/B Ratio | Market Cap (₹ Cr) |
|---|---|---|---|---|
| Murae Organisor | MURAE | 2.86 | 0.2 | ₹41 |
| Par Drugs & Chemical | PAR | 8.2 | 0.96 | ₹103 |
| Sun Pharmaceutical | SUNPHARMA | 40.81 | 5.74 | ₹450,643 |
| Jeena Sikho Lifecare | JSLL | 40.38 | 23.07 | ₹7,944 |
| Aurobindo Pharma | AUROPHARMA | 25.16 | 2.5 | ₹87,806 |
Important Disclaimer
This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.
This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.
Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.